BPG is committed to discovery and dissemination of knowledge
Featured Articles
9/11/2020 7:40:43 AM | Browse: 31 | Download: 46
Publication Name World Journal of Diabetes
Manuscript ID 58060
Country/Territory Greece
2020-07-05 06:24
Peer-Review Started
2020-07-05 06:24
To Make the First Decision
Return for Revision
2020-07-30 18:01
2020-08-02 19:51
Second Decision
2020-09-03 10:25
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2020-09-03 16:16
Articles in Press
2020-09-03 16:16
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2020-09-07 00:28
Publish the Manuscript Online
2020-09-11 07:11
ISSN 1948-9358 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Endocrinology and Metabolism
Manuscript Type Editorial
Article Title Is there a role for glucagon-like peptide-1 receptor agonists in the management of diabetic nephropathy?
Manuscript Source Invited Manuscript
All Author List Stavroula Veneti and Konstantinos Tziomalos
Funding Agency and Grant Number
Corresponding author Konstantinos Tziomalos, MD, MSc, PhD, Associate Professor, First Propedeutic Department of Internal Medicine, Medical School, Aristotle University of Thessaloniki, AHEPA Hospital, 1 Stilponos Kyriakidi Street, Thessaloniki 54636, Greece. ktziomalos@yahoo.com
Key Words Diabetic nephropathy; Type 2 diabetes mellitus; Glucagon-like peptide-1 receptor agonists; Liraglutide; Dulaglutide; Semaglutide
Core Tip Glucagon-like peptide-1 receptor agonists prevent the development of persistent macroalbuminuria in patients with type 2 diabetes mellitus. However, it is unclear whether they delay the decline in glomerular filtration rate in this population. Long-term trials are needed to clarify the role of these agents in the management of diabetic nephropathy.
Publish Date 2020-09-11 07:11
Citation Veneti S, Tziomalos K. Is there a role for glucagon-like peptide-1 receptor agonists in the management of diabetic nephropathy? World J Diabetes 2020; 11(9): 370-373
Url https://www.wjgnet.com/1948-9358/full/v11/i9/370.htm
DOI https://dx.doi.org/10.4239/wjd.v11.i9.370
Full Article (PDF) WJD-11-370.pdf
Full Article (Word) WJD-11-370.docx
Manuscript File 58060-Review.docx
Answering Reviewers 58060-Answering reviewers.pdf
Audio Core Tip 58060-Audio core tip.wma
Conflict-of-Interest Disclosure Form 58060-Conflict-of-interest statement.pdf
Copyright License Agreement 58060-Copyright license agreement.pdf
Non-Native Speakers of English Editing Certificate 58060-Language certificate.pdf
Peer-review Report 58060-Peer-review(s).pdf
Scientific Misconduct Check 58060-Scientific misconduct check.pdf
Scientific Editor Work List 58060-Scientific editor work list.pdf